Nexthera Capital

Nexthera Capital as of Dec. 31, 2017

Portfolio Holdings for Nexthera Capital

Nexthera Capital holds 38 positions in its portfolio as reported in the December 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
SPDR S&P Biotech (XBI) 31.3 $170M 2.0M 84.87
Allergan 6.3 $34M 208k 163.58
Shire 4.6 $25M 162k 155.12
BioMarin Pharmaceutical (BMRN) 4.4 $24M 268k 89.17
Mylan Nv 3.7 $20M 470k 42.31
Merck & Co (MRK) 3.6 $20M 346k 56.27
Bristol Myers Squibb (BMY) 3.3 $18M 296k 61.28
AstraZeneca (AZN) 3.0 $16M 467k 34.70
Ablynx Nv 2.9 $16M 638k 24.99
Clovis Oncology 2.9 $16M 233k 68.00
Insmed (INSM) 2.9 $16M 499k 31.18
Dova Pharmaceuticals 2.4 $13M 453k 28.80
Global Blood Therapeutics In 2.3 $12M 312k 39.35
Flexion Therapeutics 2.1 $12M 467k 25.04
Sangamo Biosciences (SGMO) 2.1 $12M 709k 16.40
Alnylam Pharmaceuticals (ALNY) 2.0 $11M 86k 127.06
Fibrogen (FGEN) 1.8 $9.5M 201k 47.40
Sage Therapeutics (SAGE) 1.7 $9.2M 56k 164.70
Sucampo Pharmaceuticals 1.7 $9.2M 511k 17.95
Alexion Pharmaceuticals 1.6 $8.7M 72k 119.59
Glycomimetics (GLYC) 1.5 $8.1M 480k 16.79
Marinus Pharmaceuticals 1.4 $7.6M 925k 8.16
Kura Oncology (KURA) 1.3 $6.8M 446k 15.30
Immunomedics 1.2 $6.5M 405k 16.16
Atara Biotherapeutics (ATRA) 1.0 $5.2M 287k 18.10
Spectrum Pharmaceuticals 0.9 $4.9M 259k 18.95
Cymabay Therapeutics (CBAY) 0.9 $4.9M 537k 9.20
Catalyst Biosciences 0.8 $4.2M 311k 13.64
Tesaro 0.8 $4.1M 50k 82.88
Flamel Technologies Sa (AVDL) 0.8 $4.1M 506k 8.20
Cytomx Therapeutics (CTMX) 0.7 $3.8M 180k 21.11
Otonomy 0.6 $3.3M 603k 5.55
Therapeuticsmd 0.6 $3.2M 528k 6.04
Biosante Pharmaceuticals (ANIP) 0.5 $2.7M 42k 64.46
Kalvista Pharmaceuticals (KALV) 0.3 $1.8M 181k 9.75
Zafgen 0.1 $792k 171k 4.62
Tg Therapeutics (TGTX) 0.1 $246k 30k 8.20
Vistagen Therapeutics 0.0 $153k 138k 1.11